Project Number 14 38 Agency/Funding Organization Alzheimer Society of Canada Funding Year 2013 View Full Project Details for Reduced BDNF signaling in cortical parvalbumin-positive inhibitory interneurons underlies cognitive impairment in Alzheimer's disease: Therapeutic role for dopamine D5 receptors Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 7. Circuits and Synapses c. Neurotransmitter Receptors Structure and Function Researcher and Organization Principal Investigator George, Susan Principal Investigator First Name Susan Principal Investigator Last Name George Awardee Organization University of Toronto Contact PI Country Canada Project Detail FY Overall Cost $150,000 Funding Organization Agency/Funding Organization Alzheimer Society of Canada Funding Organization Country Canada
